Page last updated: 2024-10-30

metformin and Parathyroid Neoplasms

metformin has been researched along with Parathyroid Neoplasms in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Parathyroid Neoplasms: Tumors or cancer of the PARATHYROID GLANDS.

Research Excerpts

ExcerptRelevanceReference
"Less than 10% of parathyroid carcinomas are non-functional, and as such, they have been rarely reported in the literature."2.45Non-functional parathyroid carcinoma: a review of the literature and report of a case requiring extensive surgery. ( Lewis, JS; Wilkins, BJ, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wilkins, BJ1
Lewis, JS1

Reviews

1 review available for metformin and Parathyroid Neoplasms

ArticleYear
Non-functional parathyroid carcinoma: a review of the literature and report of a case requiring extensive surgery.
    Head and neck pathology, 2009, Volume: 3, Issue:2

    Topics: Amlodipine; Antihypertensive Agents; Deglutition Disorders; Diabetes Mellitus, Type 2; Esophagectomy

2009